최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of hepatology : the journal of the European Association for the Study of the Liver, v.30 no.5, 1999년, pp.755 - 764
Akbar, Sk.Md.Fazle (Sk. Md. Fazle Akbar, Third Department of Internal Medicine, Ehime University School of Medicine, Shigenobu-Cho, Ehime 791-0295, Japan. Tel: 81 89 960 5308. Fax: 81 89 960 5310.) , Abe, Masanori (Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan) , Masumoto, Toshikazu (Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan) , Horiike, Norio (Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan) , Onji, Morikazu (Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan)
AbstractBackground/Aims: Vaccine therapy in which vaccine containing hepatitis B surface antigen (HBsAg) is injected has shown therapeutic activity (vaccine therapy) in some human and murine chronic hepatitis B virus (HBV)-carriers. Using HBV-transgenic mice (HBV-Tg), an animal model of the HBV-carr...
Ann Intern Med Bloom 118 298 1993 10.7326/0003-4819-118-4-199302150-00009 A reappraisal of hepatitis B virus vaccination strategies using costeffectiveness analysis
Hepatology Peters 13 977 1991 10.1002/hep.1840130529 Immunology and the liver
Annu Rev Immunol Sherker 45 475 1991 Hepadnavirus and hepatocellular carcinoma
Periollo 616 1991 Viral Hepatitis and Liver Disease Treatment of chronic hepatitis B
Antiviral Chem Chemother Shaw 7 53 1996 10.1177/095632029600700201 New approaches for antiviral chemotherapy
Vaccine Burke 11 883 1993 10.1016/0264-410X(93)90374-7 Vaccine therapy for HIV, a historic view of the treatment of infectious diseases by active specific immunization with microbe-derived antigens
J Infect Dis Stanberry 155 914 1987 10.1093/infdis/155.5.914 Vaccination with herpes simplex virus glycoproteins; protection against initial and recurrent genital herpes
Trop Geogr Med Stanford 46 93 1994 The history and future of vaccination and immunotherapy for leprosy
Biomed Pharmacother Pol 49 105 1995 10.1016/0753-3322(96)82602-3 Immunotherapy of chronic hepatitis B by anti HBV vaccine
Lancet Pol 344 342 1994 10.1016/S0140-6736(94)91384-6 Specific vaccine therapy in chronic hepatitis B infection
Lancet Wen 345 1575 1995 10.1016/S0140-6736(95)91126-X Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy
J Clin Invest Vitiello 95 341 1995 10.1172/JCI117662 Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. 1. Induction of a primary cytotoxic T lymphocyte response in humans
Proc Natl Acad Sci USA Araki 86 207 1989 10.1073/pnas.86.1.207 Expression and replication of hepatitis B virus genome in transgenic mice
J Hepatol Akbar 26 131 1997 10.1016/S0168-8278(97)80019-0 Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice
Immunology Akbar 78 468 1993 Low responsiveness of hepatitis B virus transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells
Immunology Akbar 87 519 1996 10.1046/j.1365-2567.1996.516576.x Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice: abrogation of immune response defect to a T-cell-dependent antigen
J Exp Med Metlay 171 1753 1990 10.1084/jem.171.5.1753 The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies
J Exp Med Inaba 172 631 1990 10.1084/jem.172.2.631 Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
Cell Immunol Crowley 118 108 1989 10.1016/0008-8749(89)90361-4 The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus
J Clin Invest Waters 90 2543 1992 10.1172/JCI116148 Loss of the common“A” determinant of hepatitis B surface antigen by a vaccine-induced escape mutant
Annu Rev Immunol Steinman 9 271 1991 10.1146/annurev.iy.09.040191.001415 The dendritic cell system and its role in immunogenicity
Immunology Mactonia 67 285 1989 Suppression of immune responses by dendritic cells infected with HIV.
J Exp Med Egea 173 531 1991 10.1084/jem.173.3.531 The cellular basis for lack of antibody response to hepatitis B vaccine in humans
Immunology Kurose 92 494 1997 10.1046/j.1365-2567.1997.00373.x Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells
Annu Rev Immunol Matzinger 12 991 1994 10.1146/annurev.iy.12.040194.005015 Tolerance, danger and extended family
Science Ridge 271 1723 1996 10.1126/science.271.5256.1723 Neonatal tolerance revisited: turning on newborn T cells with dendritic cells
Hepatology Chisari 22 1316 1995 Hepatitis B virus transgenic mice: insights into the virus and disease
J Immunol Schirmbeck 152 1110 1994 10.4049/jimmunol.152.3.1110 Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo
Eur J Immunol Schirmbeck 24 1010 1994 10.1002/eji.1830240512 Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monometric hepatitis B virus surface (S) antigen
Eur J Immunol Schirmbeck-R 26 2812 1996 10.1002/eji.1830261204 “Empty” Ld molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I-restricted presentation
Immunology Akbar 1998 Prognostic importance of antigen presenting dendritic cells during vaccine therapy in hepatitis B virus transgenic mice
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.